About this partner
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow.
Bio-Techne to Acquire Lunaphore
In the Know: Healthcare News for May 8, 2023
Bio-Techne Releases Third Quarter Fiscal 2023 Results
In the Know: Healthcare News for April 24, 2023